Bio-Rad and Sanofi agree bid:
This article was originally published in Clinica
Executive Summary
Sanofi-Synthelabo has reached agreement with Bio-Rad to sell its diagnostics division. Hercules, California-based Bio-Rad made a firm offer of $210 million, or one times the previous year's sales, for the Pasteur Sanofi business last month (see Clinica No 863, p 9).